Scientific advancement and increasingly complex pharmaceutical products have reshaped the healthcare industry, providing novel tools and solutions for managing broad conditions, from acute viral ...
DX Industries, Inc. provided additional details on the strategy and operating model of its recently established 3DX Advanced Systems Division. Advanced Systems is being developed to expand 3DX?s role ...
Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Modern manufacturing is shifting its focus from just the product ("what") to the entire ...
The successes seen in a number of clinical studies on viral vector-based gene therapies (AAV, retroviral, and lentiviral vectors) are well documented, with an ever-broadening pipeline of products ...
Current cell and gene manufacturing needs to catch up fast to help make the next wave of products at scale. (LuckyStep48/Getty Images) Where some gene therapy players might “go big” and put down brick ...
Historically, pharmaceutical products have been produced in a traditional ‘batch’ system, in which every operation is executed separately using a defined quantity of materials. In batch manufacturing ...
Matt Mong, VP Market Innovation at Adeaca, is the creator of the Project Business Automation category designed for project-based companies. For years the industrial sectors, no matter how specific and ...
New draft guidance issued by the US Food and Drug Administration (FDA) is intended to clarify which changes to a pharmaceutical company's manufacturing process must be reported to federal regulators, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results